Please login to the form below

Not currently logged in
Email:
Password:

Novasep promotes Jean-Claude Romain, appoints Alain Lamproye

Life sciences production company boosts management team

Novasep has boosted its management team, promoting Jean-Claude Romain to corporate quality director and appointing Alain Lamproye director of Novasep Bioproduction sites in Belgium.

The French company, which supplies purification and production services to the life sciences sector, said Romain would join its executive committee while Lamproye would sit on management committee of its biomolecules division Novasep Process.

Romain first joined Novasep in 2011, moving from Sanofi, where he served as site quality manager for nearly six years. Prior to this he worked at Galderma and Johnson & Johnson.

His promotion to the newly-created position of corporate quality director will, Novasep said, enable it to establish a “global quality management function that will ensure regulatory compliance”. 


Meanwhile, Lamproye moves to Novasep from Merck Serono, where he worked for nearly nine years, most recently as director of microbial technologies.

In his new role he will manage Novasep's two Belgian sites and head a team of more than 100 staff.

25th April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics